
Legestro 250 Injection
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Hydroxyprogesterone (250mg)
Overview Legestro 250 Injection
Pregnant women at risk of preterm birth utilize Legestro 250 Injection to delay labor, thus minimizing premature delivery. It helps prevent miscarriage and subsequent preterm births in women with a history of premature delivery. Administration is exclusively by, or under strict physician oversight. Dosage and duration are determined solely by your doctor and must be adhered to precisely. Common side effects, including injection site reactions, nausea, itching, diarrhea, and rash, should be reported to your physician; management options exist. Because it can influence blood glucose, regular monitoring is crucial. Report jaundice, dark urine, or abdominal pain immediately. Prior to treatment, disclose any history of circulatory problems, diabetes, liver disease, or other medications you are currently using, as these factors may impact Legestro 250 Injection's efficacy or mechanism.
Primary Ingredients of Legestro 250 Injection
The provided text is "undefined," which has no meaning to rephrase. Please provide the text you wish to be rewritten.
Uses of Legestro 250 Injection
Averting Preterm Birth
Major Benefits of Legestro 250 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Legestro 250 Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Legestro 250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Legestro 250 Injection works:
Legestro 250 Injection contains a progestin, a type of female hormone.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Legestro 250 Injection may pose safety risks; physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The injectable medication Legestro 250 is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences for offspring; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Legestro 250 Injection is considered safe while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Legestro 250 Injection.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Legestro 250 Injection's use in individuals with renal impairment. Physician consultation is advised. The drug's progesterone component may induce fluid retention in those with pre-existing kidney conditions.
LiverUNSAFE
The use of Legestro 250 Injection is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.
What if you forget to take Legestro 250 Injection :
Should you forget a scheduled Legestro 250 Injection, seek medical advice.
Facts to Know About Legestro 250 Injection
| Label | Value |
|---|---|
| Chemical Type | Glucocorticoids, Mineralocorticoids, and Progestins |
| Developing Habits | No. |
| Type of Therapy | OBSTETRIC AND GYNECOLOGICAL |
| Action Class | First-generation Progestins |
